SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.560-2.5%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter V who wrote (1489)6/22/1999 5:12:00 PM
From: MAELING  Read Replies (1) of 10293
 
I could see an 80% 'market penetration' for a verifiable, non-invasive screening device for bilirubin levels in neonates. You don't seem to understand the economics of the problem. Take a look at kernicterus. Estimate the net present value of the avoided cost for life time care. Now tell me if there are gradations? (ie, is there minimal disease?) Add those costs. What about the risks of phototherapy? Add those.

There's no question that a blood test would be needed for verification. A photometric device could never give you information re: bound v. unbound bilirubin. However estimation of tissue levels of bilirubin could sharpen phototherapy goals.

If you had a unit available, at least one reading would be done on EVERY admission to a neonatal unit. It is possible that the 'standard of care' could be a screening check - same as you would screen cord blood for cretinism, PKU, etc, FOR EVERY LIVE IN-HOSPITAL BIRTH. What's 80% of every birth? What's 100% market penetration?

So Girlz:

This isn't a Dog Pound. It's a Round Pound. Anyone who isn't making money in this market is spending too much time listening to the crappy information sources presented on this thread.

Thanks for the laugh. You're the tyros who make the average possible.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News